MONTAGUE, PRINCE EDWARD ISLAND--(Marketwired - Feb. 12, 2014) - SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest") announces third party confirmation of its bio-hydrogen expression system following the successful completion of a six month NSERC Engage project (previously announced) with Dr. Hallenbeck at the Université de Montréal, a world leader in bio-hydrogen production and proteomics. The study indicated that the Solarvest modified strain of microalgae produced six times more hydrogen per cell as compared to the industry standard wild-type strain. In addition, the Solarvest strain demonstrated continuous hydrogen production; producing hydrogen ten times longer when compared to the industry standard wild-type microalgae even though the laboratory growth conditions were less than optimal.

These very promising results have encouraged Solarvest and Université de Montréal to pursue another collaborative agreement to develop the mechanisms that will further improve production moving the program toward industrial production.

About Solarvest BioEnergy:

Solarvest BioEnergy Inc. is an algae technology company whose algal-based production platform provides it with an extremely flexible system capable of being adapted to produce clean energy in the form of hydrogen and health products such as Organic Omega oils in an economic and environmentally sensitive manner.

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from Solarvest's expectations and projections.

Contact Information:

Solarvest BioEnergy Inc.
Gerri Greenham
Chief Executive Officer
416 420 0947